Weiss Asset Management LP Buys Shares of 11,952 National Health Investors, Inc. $NHI

Weiss Asset Management LP purchased a new position in shares of National Health Investors, Inc. (NYSE:NHI) in the first quarter, HoldingsChannel reports. The fund purchased 11,952 shares of the real estate investment trust’s stock, valued at approximately $966,000.

Other hedge funds also recently made changes to their positions in the company. Entropy Technologies LP acquired a new stake in shares of National Health Investors in the first quarter valued at approximately $242,000. Renaissance Technologies LLC bought a new position in National Health Investors in the first quarter valued at $3,372,000. State of Wyoming acquired a new stake in National Health Investors in the 1st quarter valued at $209,000. Wealthspire Retirement LLC increased its stake in National Health Investors by 0.9% in the 1st quarter. Wealthspire Retirement LLC now owns 25,318 shares of the real estate investment trust’s stock valued at $2,047,000 after buying an additional 221 shares during the last quarter. Finally, Militia Capital Management LLC acquired a new stake in National Health Investors in the 1st quarter valued at $2,458,000. 62.51% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on NHI. Cantor Fitzgerald restated an “overweight” rating and set a $94.00 price objective on shares of National Health Investors in a research note on Wednesday, April 22nd. BMO Capital Markets lowered their target price on National Health Investors from $90.00 to $80.00 and set an “outperform” rating on the stock in a research report on Monday, June 15th. Weiss Ratings cut National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, June 12th. Zacks Research lowered National Health Investors from a “hold” rating to a “strong sell” rating in a research report on Thursday, June 25th. Finally, Truist Financial dropped their price objective on National Health Investors from $89.00 to $81.00 and set a “buy” rating on the stock in a research note on Friday, June 12th. Five investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $83.86.

National Health Investors Stock Performance

Shares of NYSE NHI opened at $79.23 on Tuesday. The company has a current ratio of 8.20, a quick ratio of 8.20 and a debt-to-equity ratio of 0.83. The company has a market capitalization of $3.84 billion, a P/E ratio of 25.56, a P/E/G ratio of 3.62 and a beta of 0.51. National Health Investors, Inc. has a 12 month low of $67.94 and a 12 month high of $91.38. The stock has a 50 day moving average of $75.09 and a 200-day moving average of $79.76.

National Health Investors Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Tuesday, June 30th will be given a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a yield of 4.6%. The ex-dividend date of this dividend is Tuesday, June 30th. National Health Investors’s payout ratio is 118.71%.

Insiders Place Their Bets

In related news, CEO D. Eric Mendelsohn acquired 1,500 shares of the company’s stock in a transaction dated Friday, June 5th. The shares were bought at an average cost of $68.84 per share, with a total value of $103,260.00. Following the completion of the transaction, the chief executive officer directly owned 133,316 shares of the company’s stock, valued at $9,177,473.44. This trade represents a 1.14% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Robert A. Mccabe, Jr. bought 890 shares of National Health Investors stock in a transaction that occurred on Monday, June 15th. The shares were bought at an average cost of $71.65 per share, with a total value of $63,768.50. Following the acquisition, the director directly owned 44,159 shares in the company, valued at $3,163,992.35. This trade represents a 2.06% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders own 2.70% of the company’s stock.

National Health Investors Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.